Emily Tonorezos named head of NCI’s Office of Cancer Survivorship

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Emily S. Tonorezos was named director of the NCI Office of Cancer Survivorship.

Tonorezos joins NCI from Memorial Sloan Kettering Cancer Center and the Weill Cornell Medical College, where she was director of the Adult Long-Term Follow-Up Program for survivors of childhood and young adult cancers.

Her research focuses on cardiometabolic consequences of cancer therapy, childhood and young adult cancer survivorship, diet and nutrition, and care coordination for this population. She was also co-leader of the International Guideline Harmonization Group for the metabolic syndrome guidelines, and she led a recent international effort to develop recommendations for adult survivors of heritable retinoblastoma.

Tonorezos replaces interim director Deborah Mayer, who led the office after retirement of Julia Rowland,

Table of Contents

YOU MAY BE INTERESTED IN

Despite steady progress in reducing overall cancer mortality rates, cancer incidence in women is rising, according to the American Cancer Society’s “Cancer Statistics, 2025” report. Incidence rates in women 50-64 years of age have surpassed those in men, and rates in women under 50 are now 82% higher than their male counterparts, up from 51% higher in 2002. In 2021, for the first time, lung cancer incidence was higher in women under 65 than in men. 
Over the past five years, Cedars-Sinai Cancer has built an integrated, regional system designed to provide cancer care close to where patients live and work. This model of care, directed by an academic medical center to patients at the community level, proved to be the best possible approach to supporting patients in our 11-million-person catchment area during the worst fire disaster in California history. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login